Disease patterns in India have undergone a dramatic shift. Non-communicable diseases are emerging as a major cause of increased morbidity and mortality. This shift necessitates lifestyle changes with continuous screening and adherence to clinical protocols. Further, chronic conditions such as anaemia continue to have a high prevalence. More than half the women of childbearing age in India are anaemic and 33% are undernourished. A malnourished mother is more likely to give birth to malnourished children. In addition, the burden of diabetes is high and increasing globally. The estimates in 2019 showed that 77 million individuals had diabetes in India, which is expected to rise to over 134 million by 2045.

Biosense has developed point-of-care devices that address extremes of anaemia, diabetes and more. Their flagship product – ToucHb – is a non-invasive anaemia screener, which means it detects anaemia without a needle poke by identifying the presence of pallor in conjunctiva. Another key product developed by Biosense is Biosense SYNC. This is a smart, all-in-one, compact sized glucometer designed for personal use. It is designed, developed and manufactured in India, and has affordable glucose test strips provided with it. Biosense uses connected diagnostics with geo-tagging. Data generated by these devices enable targeted use of scarce government resources. All its devices are portable,, and they use advanced algorithms to deliver care in under-resourced settings.